BAYER AG-REG (1BAYN.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:1BAYN • DE000BAY0017

46.3 EUR
-0.2 (-0.42%)
Last: Feb 10, 2026, 07:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to 1BAYN. 1BAYN was compared to 55 industry peers in the Pharmaceuticals industry. 1BAYN may be in some trouble as it scores bad on both profitability and health. 1BAYN has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • 1BAYN had positive earnings in the past year.
  • 1BAYN had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: 1BAYN reported negative net income in multiple years.
  • In the past 5 years 1BAYN always reported a positive cash flow from operatings.
1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCF1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -0.19%, 1BAYN is doing worse than 70.91% of the companies in the same industry.
  • With a Return On Equity value of -0.67%, 1BAYN is not doing good in the industry: 70.91% of the companies in the same industry are doing better.
  • 1BAYN has a Return On Invested Capital of 1.92%. This is in the lower half of the industry: 1BAYN underperforms 67.27% of its industry peers.
  • 1BAYN had an Average Return On Invested Capital over the past 3 years of 5.87%. This is significantly below the industry average of 14.21%.
Industry RankSector Rank
ROA -0.19%
ROE -0.67%
ROIC 1.92%
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.87%
ROIC(5y)N/A
1BAYN.MI Yearly ROA, ROE, ROIC1BAYN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

  • The Operating Margin of 1BAYN (4.20%) is worse than 69.09% of its industry peers.
  • 1BAYN's Operating Margin has declined in the last couple of years.
  • 1BAYN has a Gross Margin of 56.35%. This is in the lower half of the industry: 1BAYN underperforms 72.73% of its industry peers.
  • In the last couple of years the Gross Margin of 1BAYN has declined.
Industry RankSector Rank
OM 4.2%
PM (TTM) N/A
GM 56.35%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
1BAYN.MI Yearly Profit, Operating, Gross Margins1BAYN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1BAYN is destroying value.
  • Compared to 1 year ago, 1BAYN has about the same amount of shares outstanding.
  • Compared to 5 years ago, 1BAYN has about the same amount of shares outstanding.
  • The debt/assets ratio for 1BAYN has been reduced compared to a year ago.
1BAYN.MI Yearly Shares Outstanding1BAYN.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
1BAYN.MI Yearly Total Debt VS Total Assets1BAYN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

  • Based on the Altman-Z score of 1.03, we must say that 1BAYN is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.03, 1BAYN is not doing good in the industry: 74.55% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of 1BAYN is 10.07, which is on the high side as it means it would take 1BAYN, 10.07 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 10.07, 1BAYN is not doing good in the industry: 61.82% of the companies in the same industry are doing better.
  • 1BAYN has a Debt/Equity ratio of 1.11. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.11, 1BAYN is not doing good in the industry: 67.27% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 10.07
Altman-Z 1.03
ROIC/WACC0.27
WACC7.16%
1BAYN.MI Yearly LT Debt VS Equity VS FCF1BAYN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 1.14 indicates that 1BAYN should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.14, 1BAYN is doing worse than 63.64% of the companies in the same industry.
  • 1BAYN has a Quick Ratio of 1.14. This is a bad value and indicates that 1BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of 1BAYN (0.71) is worse than 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.71
1BAYN.MI Yearly Current Assets VS Current Liabilites1BAYN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

3

3. Growth

3.1 Past

  • 1BAYN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.72%.
  • 1BAYN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.27% yearly.
  • 1BAYN shows a decrease in Revenue. In the last year, the revenue decreased by -1.87%.
  • Measured over the past years, 1BAYN shows a small growth in Revenue. The Revenue has been growing by 1.37% on average per year.
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%

3.2 Future

  • Based on estimates for the next years, 1BAYN will show a small growth in Earnings Per Share. The EPS will grow by 3.51% on average per year.
  • Based on estimates for the next years, 1BAYN will show a small growth in Revenue. The Revenue will grow by 1.22% on average per year.
EPS Next Y-5.02%
EPS Next 2Y-1.64%
EPS Next 3Y1.75%
EPS Next 5Y3.51%
Revenue Next Year-1.56%
Revenue Next 2Y-0.38%
Revenue Next 3Y0.49%
Revenue Next 5Y1.22%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1BAYN.MI Yearly Revenue VS Estimates1BAYN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B 50B
1BAYN.MI Yearly EPS VS Estimates1BAYN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 8.67, the valuation of 1BAYN can be described as very reasonable.
  • 1BAYN's Price/Earnings ratio is rather cheap when compared to the industry. 1BAYN is cheaper than 92.73% of the companies in the same industry.
  • 1BAYN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.03.
  • 1BAYN is valuated reasonably with a Price/Forward Earnings ratio of 9.48.
  • 1BAYN's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1BAYN is cheaper than 92.73% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of 1BAYN to the average of the S&P500 Index (27.97), we can say 1BAYN is valued rather cheaply.
Industry RankSector Rank
PE 8.67
Fwd PE 9.48
1BAYN.MI Price Earnings VS Forward Price Earnings1BAYN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 61.82% of the companies in the same industry are more expensive than 1BAYN, based on the Enterprise Value to EBITDA ratio.
  • 87.27% of the companies in the same industry are more expensive than 1BAYN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.56
EV/EBITDA 12.45
1BAYN.MI Per share data1BAYN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.64%
EPS Next 3Y1.75%

0

5. Dividend

5.1 Amount

  • 1BAYN has a yearly dividend return of 0.25%, which is pretty low.
  • Compared to an average industry Dividend Yield of 1.94, 1BAYN is paying slightly less dividend.
  • With a Dividend Yield of 0.25, 1BAYN pays less dividend than the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 0.25%

5.2 History

  • The dividend of 1BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • The earnings of 1BAYN are negative and hence is the payout ratio. 1BAYN will probably not be able to sustain this dividend level.
DP-65.15%
EPS Next 2Y-1.64%
EPS Next 3Y1.75%
1BAYN.MI Yearly Income VS Free CF VS Dividend1BAYN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

BAYER AG-REG

BIT:1BAYN (2/10/2026, 7:00:00 PM)

46.3

-0.2 (-0.42%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-12
Earnings (Next)02-25
Inst Owners49.57%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap45.49B
Revenue(TTM)45.87B
Net Income(TTM)-198.00M
Analysts74.29
Price Target42.2 (-8.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.25%
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-65.15%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.52%
Min EPS beat(2)45.89%
Max EPS beat(2)71.16%
EPS beat(4)4
Avg EPS beat(4)30.58%
Min EPS beat(4)1.86%
Max EPS beat(4)71.16%
EPS beat(8)7
Avg EPS beat(8)18.15%
EPS beat(12)9
Avg EPS beat(12)7.9%
EPS beat(16)12
Avg EPS beat(16)7.93%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-2.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.69%
Revenue beat(12)2
Avg Revenue beat(12)-2.67%
Revenue beat(16)6
Avg Revenue beat(16)-1.42%
PT rev (1m)25.79%
PT rev (3m)45.17%
EPS NQ rev (1m)11.15%
EPS NQ rev (3m)-30.17%
EPS NY rev (1m)0.15%
EPS NY rev (3m)1.01%
Revenue NQ rev (1m)0.54%
Revenue NQ rev (3m)-1.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE 8.67
Fwd PE 9.48
P/S 0.99
P/FCF 11.56
P/OCF 6.77
P/B 1.54
P/tB N/A
EV/EBITDA 12.45
EPS(TTM)5.34
EY11.53%
EPS(NY)4.89
Fwd EY10.55%
FCF(TTM)4.01
FCFY8.65%
OCF(TTM)6.84
OCFY14.78%
SpS46.69
BVpS30.11
TBVpS-18.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number60.14
Profitability
Industry RankSector Rank
ROA -0.19%
ROE -0.67%
ROCE 2.56%
ROIC 1.92%
ROICexc 2.13%
ROICexgc 7.24%
OM 4.2%
PM (TTM) N/A
GM 56.35%
FCFM 8.58%
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.87%
ROIC(5y)N/A
ROICexc(3y)6.62%
ROICexc(5y)N/A
ROICexgc(3y)27.47%
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3Y-23.46%
ROICexgc growth 5Y-1.27%
ROICexc growth 3Y-13.2%
ROICexc growth 5Y2.54%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 10.07
Debt/EBITDA 5.32
Cap/Depr 66.1%
Cap/Sales 6.08%
Interest Coverage 1.09
Cash Conversion 109.39%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.71
Altman-Z 1.03
F-Score5
WACC7.16%
ROIC/WACC0.27
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
EPS Next Y-5.02%
EPS Next 2Y-1.64%
EPS Next 3Y1.75%
EPS Next 5Y3.51%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
Revenue Next Year-1.56%
Revenue Next 2Y-0.38%
Revenue Next 3Y0.49%
Revenue Next 5Y1.22%
EBIT growth 1Y-2.82%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year65.28%
EBIT Next 3Y21.41%
EBIT Next 5Y12.99%
FCF growth 1Y873.08%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y161.6%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%

BAYER AG-REG / 1BAYN.MI FAQ

What is the fundamental rating for 1BAYN stock?

ChartMill assigns a fundamental rating of 2 / 10 to 1BAYN.MI.


What is the valuation status of BAYER AG-REG (1BAYN.MI) stock?

ChartMill assigns a valuation rating of 6 / 10 to BAYER AG-REG (1BAYN.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for BAYER AG-REG?

BAYER AG-REG (1BAYN.MI) has a profitability rating of 2 / 10.


What are the PE and PB ratios of BAYER AG-REG (1BAYN.MI) stock?

The Price/Earnings (PE) ratio for BAYER AG-REG (1BAYN.MI) is 8.67 and the Price/Book (PB) ratio is 1.54.


Can you provide the expected EPS growth for 1BAYN stock?

The Earnings per Share (EPS) of BAYER AG-REG (1BAYN.MI) is expected to decline by -5.02% in the next year.